315 related articles for article (PubMed ID: 34831354)
1. Reciprocal Regulation of Hippo and WBP2 Signalling-Implications in Cancer Therapy.
Lim YX; Lin H; Seah SH; Lim YP
Cells; 2021 Nov; 10(11):. PubMed ID: 34831354
[TBL] [Abstract][Full Text] [Related]
2. WBP2 negatively regulates the Hippo pathway by competitively binding to WWC3 with LATS1 to promote non-small cell lung cancer progression.
Han Q; Rong X; Lin X; Zhang X; Fan C; Zhao H; Wang E
Cell Death Dis; 2021 Apr; 12(4):384. PubMed ID: 33837178
[TBL] [Abstract][Full Text] [Related]
3. WBP2 promotes gastric cancer cell migration via novel targeting of LATS2 kinase in the Hippo tumor suppressor pathway.
Hum M; Tan HJ; Yang Y; Srivastava S; Teh M; Lim YP
FASEB J; 2021 Feb; 35(2):e21290. PubMed ID: 33475198
[TBL] [Abstract][Full Text] [Related]
4. WW domain-mediated interaction with Wbp2 is important for the oncogenic property of TAZ.
Chan SW; Lim CJ; Huang C; Chong YF; Gunaratne HJ; Hogue KA; Blackstock WP; Harvey KF; Hong W
Oncogene; 2011 Feb; 30(5):600-10. PubMed ID: 20972459
[TBL] [Abstract][Full Text] [Related]
5. Hippo/MST blocks breast cancer by downregulating WBP2 oncogene expression via miRNA processor Dicer.
Lim SK; Tabatabaeian H; Lu SY; Kang SA; Sundaram GM; Sampath P; Chan SW; Hong WJ; Lim YP
Cell Death Dis; 2020 Aug; 11(8):669. PubMed ID: 32820148
[TBL] [Abstract][Full Text] [Related]
6. The transcriptional coactivator WBP2 primes triple-negative breast cancer cells for responses to Wnt signaling via the JNK/Jun kinase pathway.
Li Z; Lim SK; Liang X; Lim YP
J Biol Chem; 2018 Dec; 293(52):20014-20028. PubMed ID: 30442712
[TBL] [Abstract][Full Text] [Related]
7. The emerging roles of WBP2 oncogene in human cancers.
Tabatabaeian H; Rao A; Ramos A; Chu T; Sudol M; Lim YP
Oncogene; 2020 Jun; 39(24):4621-4635. PubMed ID: 32393834
[TBL] [Abstract][Full Text] [Related]
8. Wnt Signaling Promotes Breast Cancer by Blocking ITCH-Mediated Degradation of YAP/TAZ Transcriptional Coactivator WBP2.
Lim SK; Lu SY; Kang SA; Tan HJ; Li Z; Adrian Wee ZN; Guan JS; Reddy Chichili VP; Sivaraman J; Putti T; Thike AA; Tan PH; Sudol M; Virshup DM; Chan SW; Hong W; Lim YP
Cancer Res; 2016 Nov; 76(21):6278-6289. PubMed ID: 27578003
[TBL] [Abstract][Full Text] [Related]
9. WBP2 inhibits microRNA biogenesis via interaction with the microprocessor complex.
Tabatabaeian H; Lim SK; Chu T; Seah SH; Lim YP
Life Sci Alliance; 2021 Jul; 4(7):. PubMed ID: 34117091
[TBL] [Abstract][Full Text] [Related]
10. The Hippo pathway in cancer: YAP/TAZ and TEAD as therapeutic targets in cancer.
Cunningham R; Hansen CG
Clin Sci (Lond); 2022 Feb; 136(3):197-222. PubMed ID: 35119068
[TBL] [Abstract][Full Text] [Related]
11. WBP2 promotes BTRC mRNA stability to drive migration and invasion in triple-negative breast cancer via NF-κB activation.
Lim YX; Lin H; Chu T; Lim YP
Mol Oncol; 2022 Jan; 16(2):422-446. PubMed ID: 34197030
[TBL] [Abstract][Full Text] [Related]
12. WW domain-binding protein 2: an adaptor protein closely linked to the development of breast cancer.
Chen S; Wang H; Huang YF; Li ML; Cheng JH; Hu P; Lu CH; Zhang Y; Liu N; Tzeng CM; Zhang ZM
Mol Cancer; 2017 Jul; 16(1):128. PubMed ID: 28724435
[TBL] [Abstract][Full Text] [Related]
13. Wbp2 cooperates with Yorkie to drive tissue growth downstream of the Salvador-Warts-Hippo pathway.
Zhang X; Milton CC; Poon CL; Hong W; Harvey KF
Cell Death Differ; 2011 Aug; 18(8):1346-55. PubMed ID: 21311569
[TBL] [Abstract][Full Text] [Related]
14. Reciprocal regulation of YAP/TAZ by the Hippo pathway and the Small GTPase pathway.
Jang JW; Kim MK; Bae SC
Small GTPases; 2020 Jul; 11(4):280-288. PubMed ID: 29457552
[TBL] [Abstract][Full Text] [Related]
15. Identification of Prolyl isomerase Pin1 as a novel positive regulator of YAP/TAZ in breast cancer cells.
Khanal P; Yeung B; Zhao Y; Yang X
Sci Rep; 2019 Apr; 9(1):6394. PubMed ID: 31015482
[TBL] [Abstract][Full Text] [Related]
16. The Hippo Pathway in Prostate Cancer.
Salem O; Hansen CG
Cells; 2019 Apr; 8(4):. PubMed ID: 31018586
[TBL] [Abstract][Full Text] [Related]
17. A genome-wide screen identifies YAP/WBP2 interplay conferring growth advantage on human epidermal stem cells.
Walko G; Woodhouse S; Pisco AO; Rognoni E; Liakath-Ali K; Lichtenberger BM; Mishra A; Telerman SB; Viswanathan P; Logtenberg M; Renz LM; Donati G; Quist SR; Watt FM
Nat Commun; 2017 Mar; 8():14744. PubMed ID: 28332498
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation of E-box binding USF-1 by PI3K/AKT enhances its transcriptional activation of the WBP2 oncogene in breast cancer cells.
Ramos A; Miow QH; Liang X; Lin QS; Putti TC; Lim YP
FASEB J; 2018 Sep; ():fj201801167RR. PubMed ID: 30183375
[TBL] [Abstract][Full Text] [Related]
19. YAP/TAZ for cancer therapy: opportunities and challenges (review).
Guo L; Teng L
Int J Oncol; 2015 Apr; 46(4):1444-52. PubMed ID: 25652178
[TBL] [Abstract][Full Text] [Related]
20. microRNA-485-5p inhibits the progression of hepatocellular carcinoma through blocking the WBP2/Wnt signaling pathway.
Gao J; Dai C; Yu X; Yin XB; Zhou F
Cell Signal; 2020 Feb; 66():109466. PubMed ID: 31706018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
